SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wasserman K. Principles of Exercise Testing and Interpretation. Lippincott Williams and Wilkins, Philadelphia, 2004.
  • 2
    Maltais F, Sullivan MJ, LeBlanc P et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur. Respir. J. 1999; 13: 8504.
  • 3
    Rabinovich RA, Ardite E, Troosters T et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 111418.
  • 4
    Whittom F, Jobin J, Simard PM et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med. Sci. Sports Exerc. 1998; 30: 146774.
  • 5
    Couillard A, Maltais F, Saey D et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 16649.
  • 6
    Jobin J, Maltais F, Doyon J-F et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J. Cardiopulm. Rehabil. 1998; 18: 4327.
  • 7
    Maltais F, LeBlanc P, Whittom F et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000; 55: 84853.
  • 8
    Sala E, Roca J, Marrades RM et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 172634.
  • 9
    Maltais F, Jobin J, Sullivan MJ et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J. Appl. Physiol. 1998; 84: 157380.
  • 10
    Debigare R, Marquis K, Cote CH et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124: 839.
  • 11
    DiFrancia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994; 150: 14535.
  • 12
    Kamischke A, Kemper DE, Castel MA et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur. Respir. J. 1998; 11: 415.
  • 13
    Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiological and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann. Intern. Med. 1995; 122: 82332.
  • 14
    Jones NL, Jones G, Edwards RHT. Exercise tolerance in chronic airway obstruction. Am. Rev. Respir. Dis. 1971; 103: 47791.
  • 15
    Richardson RS, Leek BT, Gavin TP et al. Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise. Am. J. Respir. Crit. Care Med. 2004; 169: 8996.
  • 16
    Debigare R, Cote CH, Hould FS, LeBlanc P, Maltais F. In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. Eur. Respir. J. 2003; 21: 2738.
  • 17
    Bernard S, LeBlanc P, Whittom F et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 158: 62934.
  • 18
    Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am. Rev. Respir. Dis 1991; 143: 918.
  • 19
    Sauleda J, Garcia-Palmer F, Wiesner RJ et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 141317.
  • 20
    Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 17: 93945.
  • 21
    Larsson L, Ansved T. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man. Muscle Nerve 1985; 8: 71422.
  • 22
    Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003; 124: 173342.
  • 23
    Burdet L, De Muralt B, Schutz Y, Pichard C, Fitting J-W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 1997; 156: 18006.
  • 24
    Ji LL, Leeuwenburgh C, Leichtweis S et al. Oxidative stress and aging: role of exercise and its influences on antioxidant systems. Ann. NY Acad. Sci. 1998; 854: 10217.
  • 25
    Kosmidou I, Xagorari A, Roussos C, Papapetropoulos A. Reactive oxygen species stimulate VEGF production from C(2)C(12) skeletal myotubes through a P13K/Akt pathway. Am. J. Physiol. 2001; 280: L58592.
  • 26
    Maltais F, LeBlanc P, Simard C et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996; 154: 4427.
  • 27
    Maltais F, LeBlanc P, Jobin J et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997; 155: 55561.
  • 28
    Bernard S, Whittom F, LeBlanc P et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 896901.